Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.94 |
| ▸ | CA1 | P00915 | 3/20 | 0.94 |
| ▸ | CA12 | O43570 | 1/20 | 0.94 |
| ▸ | CA3 | P07451 | 1/20 | 0.94 |
| ▸ | TYR | P14679 | 1/20 | 0.94 |
| ▸ | DRD1 | P21728 | 1/20 | 0.94 |
| ▸ | CA4 | P22748 | 1/20 | 0.94 |
| ▸ | CA6 | P23280 | 1/20 | 0.94 |
| ▸ | CA5A | P35218 | 1/20 | 0.94 |
| ▸ | CA7 | P43166 | 1/20 | 0.94 |
| ▸ | CA9 | Q16790 | 1/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.94 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.94 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.80 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Paraben SCHEMBL7622776 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL20500516 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Terephthalic Acid SCHEMBL6692916 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL5311518 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Terephthalic Acid SCHEMBL3460105 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL3212865 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL4110 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL2488395 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL21061691 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL10606180 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| CN-107635589-A | Essentially antimicrobial porous matrix composites and methods of making the same | 约翰·保罗·威尔逊 | 2018-01-26 | — | — | CN | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-12545860-B2 | Mannanase variants | BASF SE (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| EP-4676433-A1 | LIQUID UV FILTER CONCENTRATE | Symrise AG (DE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676428-A1 | LIQUID UV FILTER COMPOSITION CONTAINING DIOLS | Symrise AG (DE) | 2026-01-14 | — | — | EP | disclosed |
| WO-2004092283-A2 | ANTIMICROBIAL PIGMENTS | MERCK PATENT GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004091567-A2 | COSMETIC FORMULATIONS COMPRISING ANTIMICROBIAL PIGMENTS | MERCK PATENT GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004087740-A2 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | PROCYTE CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-6800671-B1 | UNSATURATED COMPOUND, ADHESION PROMOTER AND CURING AGENT; FLEXIBLE BIOADHESIVES | BRITESMILE, INC. | 2004-10-05 | — | — | US | disclosed |
| WO-2001081437-A1 | LOW PEAK EXOTHERM CURABLE COMPOSITIONS | BRITESMILE, INC. (US) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | CA2 4525/4885CA1 4875/4885CA12 4850/4885 |
| US-12545860-B2 | Mannanase variants | MAN2A1, MANBA, IDUA | CA2 4162/4885CA1 4163/4885CA12 3172/4885 |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | AOC1, NONO, CUTA | CA2 1848/4885CA1 890/4885CA12 1650/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | CA2 4757/4885CA1 4868/4885CA12 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.